Julia Aijun Wang - 28 Feb 2022 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Chief Financial Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
BGNE
Transactions as of
28 Feb 2022
Transactions value $
$0
Form type
4
Filing time
02 Mar 2022, 16:12:42
Previous filing
01 Jul 2021
Next filing
21 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Award $0 +61.8K +75.72% $0.00 143K 28 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of February 28, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
F2 Includes 1,677 ordinary shares acquired pursuant to the Company's Second Amended and Restated 2018 Employee Share Purchase Plan.